Docality.com Logo
 
Dr. Sajit  Bux  M D image

Dr. Sajit Bux M D

1850 Gateway Dr
Sycamore IL 60178
815 588-8671
Medical School: Other - 1993
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: Yes
Participates In EHR: Yes
License #: 036110772
NPI: 1467488957
Taxonomy Codes:
208800000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Sajit Bux is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:52648 Description:Laser surgery of prostate Average Price:$1,869.65 Average Price Allowed
By Medicare:
$678.81
HCPCS Code:52224 Description:Cystoscopy and treatment Average Price:$754.02 Average Price Allowed
By Medicare:
$162.28
HCPCS Code:52332 Description:Cystoscopy and treatment Average Price:$502.09 Average Price Allowed
By Medicare:
$97.47
HCPCS Code:50590 Description:Fragmenting of kidney stone Average Price:$947.47 Average Price Allowed
By Medicare:
$611.60
HCPCS Code:76942 Description:Echo guide for biopsy Average Price:$189.95 Average Price Allowed
By Medicare:
$32.67
HCPCS Code:51784 Description:Anal/urinary muscle study Average Price:$187.96 Average Price Allowed
By Medicare:
$94.56
HCPCS Code:76872 Description:Us transrectal Average Price:$122.80 Average Price Allowed
By Medicare:
$33.66
HCPCS Code:55700 Description:Biopsy of prostate Average Price:$219.12 Average Price Allowed
By Medicare:
$134.27
HCPCS Code:55700 Description:Biopsy of prostate Average Price:$286.97 Average Price Allowed
By Medicare:
$215.67
HCPCS Code:76942 Description:Echo guide for biopsy Average Price:$237.15 Average Price Allowed
By Medicare:
$187.31
HCPCS Code:52649 Description:Prostate laser enucleation Average Price:$878.24 Average Price Allowed
By Medicare:
$829.81
HCPCS Code:76872 Description:Us transrectal Average Price:$154.83 Average Price Allowed
By Medicare:
$121.36
HCPCS Code:51741 Description:Electro-uroflowmetry first Average Price:$36.91 Average Price Allowed
By Medicare:
$18.76
HCPCS Code:51797 Description:Intraabdominal pressure test Average Price:$116.98 Average Price Allowed
By Medicare:
$112.14
HCPCS Code:52000 Description:Cystoscopy Average Price:$200.85 Average Price Allowed
By Medicare:
$196.27
HCPCS Code:82565 Description:Assay of creatinine Average Price:$7.91 Average Price Allowed
By Medicare:
$4.12
HCPCS Code:52353 Description:Cystouretero w/lithotripsy Average Price:$427.59 Average Price Allowed
By Medicare:
$424.31
HCPCS Code:84520 Description:Assay of urea nitrogen Average Price:$6.26 Average Price Allowed
By Medicare:
$3.19
HCPCS Code:52281 Description:Cystoscopy and treatment Average Price:$273.64 Average Price Allowed
By Medicare:
$271.08
HCPCS Code:51798 Description:Us urine capacity measure Average Price:$19.90 Average Price Allowed
By Medicare:
$17.78
HCPCS Code:99215 Description:Office/outpatient visit est Average Price:$137.64 Average Price Allowed
By Medicare:
$135.53
HCPCS Code:84153 Description:Assay of psa total Average Price:$27.58 Average Price Allowed
By Medicare:
$25.89
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$102.27 Average Price Allowed
By Medicare:
$100.69
HCPCS Code:87086 Description:Urine culture/colony count Average Price:$11.91 Average Price Allowed
By Medicare:
$11.36
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$68.38 Average Price Allowed
By Medicare:
$67.97
HCPCS Code:96402 Description:Chemo hormon antineopl sq/im Average Price:$31.70 Average Price Allowed
By Medicare:
$31.36
HCPCS Code:80053 Description:Comprehen metabolic panel Average Price:$14.94 Average Price Allowed
By Medicare:
$14.60
HCPCS Code:36415 Description:Routine venipuncture Average Price:$3.30 Average Price Allowed
By Medicare:
$3.00
HCPCS Code:80048 Description:Metabolic panel total ca Average Price:$11.91 Average Price Allowed
By Medicare:
$11.65
HCPCS Code:93005 Description:Electrocardiogram tracing Average Price:$9.89 Average Price Allowed
By Medicare:
$9.74
HCPCS Code:81001 Description:Urinalysis auto w/scope Average Price:$4.60 Average Price Allowed
By Medicare:
$4.45
HCPCS Code:99212 Description:Office/outpatient visit est Average Price:$40.67 Average Price Allowed
By Medicare:
$40.67
HCPCS Code:J9217 Description:Leuprolide acetate suspnsion Average Price:$215.00 Average Price Allowed
By Medicare:
$214.99
HCPCS Code:99232 Description:Subsequent hospital care Average Price:$68.90 Average Price Allowed
By Medicare:
$68.90
HCPCS Code:99203 Description:Office/outpatient visit new Average Price:$101.94 Average Price Allowed
By Medicare:
$101.94
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$156.82 Average Price Allowed
By Medicare:
$156.82
HCPCS Code:87186 Description:Microbe susceptible mic Average Price:$12.17 Average Price Allowed
By Medicare:
$12.17
HCPCS Code:51729 Description:Cystometrogram w/vp&up Average Price:$312.86 Average Price Allowed
By Medicare:
$312.86
HCPCS Code:87088 Description:Urine bacteria culture Average Price:$11.40 Average Price Allowed
By Medicare:
$11.40
HCPCS Code:99222 Description:Initial hospital care Average Price:$132.25 Average Price Allowed
By Medicare:
$132.25
HCPCS Code:99221 Description:Initial hospital care Average Price:$97.96 Average Price Allowed
By Medicare:
$97.96
HCPCS Code:99205 Description:Office/outpatient visit new Average Price:$194.96 Average Price Allowed
By Medicare:
$194.96
HCPCS Code:51728 Description:Cystometrogram w/vp Average Price:$293.39 Average Price Allowed
By Medicare:
$293.39
HCPCS Code:85025 Description:Complete cbc w/auto diff wbc Average Price:$10.94 Average Price Allowed
By Medicare:
$10.94
HCPCS Code:87077 Description:Culture aerobic identify Average Price:$5.97 Average Price Allowed
By Medicare:
$5.97

HCPCS Code Definitions

J9217
Leuprolide acetate (for depot suspension), 7.5 mg
99203
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A detailed history; A detailed examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face with the patient and/or family.
76872
Ultrasound, transrectal
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
96402
Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
93005
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report
99232
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
51784
Electromyography studies (EMG) of anal or urethral sphincter, other than needle, any technique
51797
Voiding pressure studies, intra-abdominal (ie, rectal, gastric, intraperitoneal) (List separately in addition to code for primary procedure)
76872
Ultrasound, transrectal
52332
Cystourethroscopy, with insertion of indwelling ureteral stent (eg, Gibbons or double-J type)
51741
Complex uroflowmetry (eg, calibrated electronic equipment)
51729
Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure) and urethral pressure profile studies (ie, urethral closure pressure profile), any technique
52281
Cystourethroscopy, with calibration and/or dilation of urethral stricture or stenosis, with or without meatotomy, with or without injection procedure for cystography, male or female
52224
Cystourethroscopy, with fulguration (including cryosurgery or laser surgery) or treatment of MINOR (less than 0.5 cm) lesion(s) with or without biopsy
52000
Cystourethroscopy (separate procedure)
51798
Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging
99222
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.
99221
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of low severity. Typically, 30 minutes are spent at the bedside and on the patient's hospital floor or unit.
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99205
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-to-face with the patient and/or family.
76942
Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation
99212
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
99215
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
76942
Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation
55700
Biopsy, prostate; needle or punch, single or multiple, any approach
50590
Lithotripsy, extracorporeal shock wave
51728
Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique
55700
Biopsy, prostate; needle or punch, single or multiple, any approach
52649
Laser enucleation of the prostate with morcellation, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, internal urethrotomy and transurethral resection of prostate are included if performed)
52648
Laser vaporization of prostate, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, internal urethrotomy and transurethral resection of prostate are included if performed)
52353
Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lithotripsy (ureteral catheterization is included)

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1437168671
Internal Medicine
6,539
1598819575
Medical Oncology
6,305
1306824511
Diagnostic Radiology
4,742
1164577102
Hematology/Oncology
3,073
1588631378
Internal Medicine
3,042
1326072042
Internal Medicine
2,901
1629084579
Pulmonary Disease
2,412
1437103314
Orthopedic Surgery
1,757
1356367338
Neurology
1,474
1942317839
Diagnostic Radiology
1,453
*These referrals represent the top 10 that Dr. Bux has made to other doctors

Publications

New classes of carborane-appended 5-thio-D-glucopyranose derivatives. - Dalton transactions (Cambridge, England : 2003)
A series of carborane-appended 5-thio-D-glucopyranose (5-TDGP) derivatives containing one to two 5-TDGP moieties were synthesized via click cycloaddition reaction as well as following the traditional methods. Among the carboranyl-5-TDGP derivatives, the decapitated nido-carboranyl derivative 18 was found to be highly water-soluble and therefore its preliminary biodistribution study was conducted. A comparative biological evaluation of 18 versus its carboranyl-D-glucopyranose analog 19 with human hepatocellular carcinoma cells (SK-Hep1) indicated 5-TDGP to be a better boron carrier than normal D-glucopyranose. The carboranyl-5-TDGP 18 showed a nearly two fold increase in cellular boron accumulation than carboranyl-D-glucopyranose analog 19 over a period of 2 h. The accumulation of both 18 and 19 was found to occur in a temperature dependent manner. The higher accumulation of 18 suggested excellent promise for it to be a candidate for further evaluation as a future BNCT agent.
Boron neutron capture in prostate cancer cells. - Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
A modified enhanced thermal neutron beam (METNB) assembly at Fermilab was used to irradiate borylphenylalanine (BPA) treated human prostate cancer cells, DU 145. Acceptable cellular uptake levels of BPA and no BPA cytotoxicity were observed. In the absence of BPA, the relative biological effectiveness (RBE) of the METNB was determined to be 2.3-4.8 times greater than gamma rays. An additional 1.2 or 1.4 fold relative enhancement from boron neutron capture (RE(BNC)) was observed for METNB irradiated DU 145 cells treated with 4.9 or 12mM BPA, respectively. The additional cell killing of the BPA loaded DU 145 cells by the METNB at Fermilab is evidence for a BNC enhanced cell killing.Copyright © 2011 Elsevier Ltd. All rights reserved.
Contemporary management of renal trauma. - The West Virginia medical journal
The genitourinary tract is frequently involved in various types of trauma to the chest, abdomen and pelvis. Genitourinary trauma is typically divided into upper tract trauma and lower tract trauma. Upper tract trauma involves injury to kidney and ureter while lower tract trauma typically involves bladder or urethral injury. This review will focus on current trends in the diagnosis, evaluation and treatment of renal trauma.
Evaluation of a new serum testing method for detection of prostate cancer. - The Journal of urology
Serum prostate specific antigen is a highly specific test for diseases of the prostate gland but it is not specific for prostate cancer, which can lead to unnecessary biopsies. In an effort to find a more specific test, a new testing method for detecting prostate cancer based on deglycosylation of cell surface proteins and subsequent antibody formation in patients with prostate cancer was evaluated. In addition, antibody generation against the peptide fragments chosen to represent the cell surface proteins was determined to be cancer associated, cancer specific or not related to prostate cancer.Antibody titers to 67 unique peptide sequences representing 41 cell surface proteins were determined in 25 men with known prostate cancer (cancer group) and 34 men without prostate cancer (control group). The titers of the control and cancer groups were compared for statistical significance. Additionally, each peptide was identified as being cancer specific, cancer associated or not related to prostate cancer based on whether patients, controls, both or neither had elevated antibody titers.Of the 67 peptides tested 3 demonstrated statistical significance between the control and cancer group titers. Using these 3 informative peptides, 11 of the 25 men known to have prostate cancer had positive results (sensitivity 44%), while 2 of the 34 control patients had positive results (specificity 94%). Of the peptides with significantly different titers in patients and controls 2 of the 19 cell surface proteins known to be present in prostate cancer were represented. No peptides were found to generate antibodies only in patients with cancer (cancer specific), while 3 were cancer associated (increased in cancer and controls).A new approach to testing for prostate cancer, although lacking in sensitivity, appears to be highly specific. The high specificity of this test suggests that when combined with a highly sensitive test, such as prostate specific antigen, screening could be significantly improved.

Map & Directions

1850 Gateway Dr Sycamore, IL 60178
View Directions In Google Maps

Nearby Doctors

2180 Oakland Dr Unit A
Sycamore, IL 60178
815 694-4811
404 S Main St
Sycamore, IL 60178
815 997-7084
225 Edward St
Sycamore, IL 60178
815 952-2144
1985 Dekalb Ave Suite 300
Sycamore, IL 60178
815 541-1122
2127 Midlands Ct Suite200
Sycamore, IL 60178
815 588-8106
2550 Hauser Ross Drive Suite 325
Sycamore, IL 60178
815 587-7700
2025 Aberdeen Court
Sycamore, IL 60178
815 583-3666
920 W Prairie Dr Ste. J
Sycamore, IL 60178
815 953-3354
1225 E State St
Sycamore, IL 60178
815 915-5569
1850 Gateway Dr
Sycamore, IL 60178
815 588-8671